New beta-2-agonists prolonged effect and their use as medicaments.

15) A pharmaceutical formulation inhalation application, characterized by a content of a compound of formula 1 according to one of claims 1 to 11. 16) A pharmaceutical formulation administration by inhalation according to claim 15, characterized in that it is selected the group consisting of inhalable powders, metering aerosols containing propellant gas and propellant-free inhalable solutions gas. 59 27 Case